From 1 January 2017 HPV vaccine is funded for everyone aged 26 years and under.
Initially, HPV9 (Gardasil 9) will be used in school-based programmes only. HPV4 (Gardasil) will continue to be used in primary and secondary care until existing stocks are used up, and then HPV9 will be used. Those who started with HPV4 may complete the course with HPV4 or with HPV9 when available.
If you would like to arrange a short (15-20 minute) HPV update session for staff please contact Sian Gilhooley on 0275 504 916 or email Imms@comprehensivecare.co.nz.
The following documents related to the changes are available:
- Immunisation Advisory Centre’s Answers to frequent human papillomavirus related questions (PDF, 4 pages, 145KB)
- Flow chart on clinical administration guidelines for HPV Gardasil (PDF, 1 page, 47KB)
- Release Notes for Medtech32 (PDF, 8 pages, 947KB)
In addition, the Immunisation Handbook chapter on HPV has been updated and can be accessed online at www.health.govt.nz/system/files/documents/publications/changes-immunisation-handbook-2014-3rded-dec2016.pdf (PDF, 8 pages).
Date posted: 10 January, 2017